Natixis Advisors LLC Purchases 1,337 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)
Natixis Advisors LLC increased its position in shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) by 3.0% in the 4th quarter, HoldingsChannel reports. The firm owned 45,683 shares of the company’s stock after acquiring an additional 1,337 shares during the quarter. Natixis Advisors LLC’s holdings in Crinetics Pharmaceuticals were worth $2,336,000 at the end […]
More Stories
The Golden Rule: He Who Has the Gold Makes the Rules
By Rodd Mann “O Gold! I still prefer thee unto paper, which makes bank credit like a bark of vapor.”—Lord...
The Golden Rule: He Who Has the Gold Makes the Rules
By Rodd Mann “O Gold! I still prefer thee unto paper, which makes bank credit like a bark of vapor.”—Lord...
The Golden Rule: He Who Has the Gold Makes the Rules
By Rodd Mann “O Gold! I still prefer thee unto paper, which makes bank credit like a bark of vapor.”—Lord...
Pipeline Projects Prioritized for Quick Approval Under Emergency Energy Orders
By John Haughey More than 220 natural gas pipeline-related proposals across 22 states are among nearly 700 projects that could...
Pipeline Projects Prioritized for Quick Approval Under Emergency Energy Orders
By John Haughey More than 220 natural gas pipeline-related proposals across 22 states are among nearly 700 projects that could...
Pipeline Projects Prioritized for Quick Approval Under Emergency Energy Orders
By John Haughey More than 220 natural gas pipeline-related proposals across 22 states are among nearly 700 projects that could...